Matthew RimmerUC Berkeley assistant vice chancellor for intellectual property and industry research alliances questions #TRIPSWaiver proposal: San Diego's biotech industry would suffer greatly under WTO's proposed patent waivers https://www.sandiegouniontribune.com/opinion/commentary/story/2023-12-29/opinion-san-diego-biotech-covid-test-wto-patent-waivers #patent #education #access2meds #COVID19
kauer@drrimmer Yes, because investor profits are so much more important than the lives saved by cheap, ubiquitous testing. Tell them they can have either their patents or their extensive government funding, but not both.